Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Kainos Progresses Parkinson’s Drug US Trials Amid Deal Prospects
US Phase II Study Of FAF1 Inhibitor Begins
Jul 14 2022
•
By
Jung Won Shin
Could KM-819 Be The First Disease Modifying Drug For Parkinson’s? • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from R&D
More from Scrip